TY - JOUR
T1 - Anti-stigma interventions in low-income and middle-income countries
T2 - a systematic review
AU - Majeed, Tazeen
AU - Hopkin, Gareth
AU - Wang, Katie
AU - Nepal, Smriti
AU - Votruba, Nicole
AU - Gronholm, Petra
AU - Gurung, Dristy
AU - Semrau, Maya
AU - Bagade, Tanmay
AU - Farina, Nick
AU - Musyimi, Christine
AU - Pingani, Luca
AU - Breuer, Erica
AU - Lund, Crick
AU - Thornicroft, Graham
AU - Evans-Lacko, Sara
N1 - Funding Information:
This study is supported by the UK Medical Research Council Indigo Partnership (MR/R023697/1) award.This study is supported by the UK Medical Research Council Indigo Partnership (MR/R023697/1) award. GT is supported by the National Institute for Health Research (NIHR) Applied Research Collaboration South London at King's College London NHS Foundation Trust, and by the NIHR Asset Global Health Unit award. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. GT is also supported by the Guy's and St Thomas' Charity for the On Trac project (EFT151101), and by the UK Medical Research Council (UKRI) in relation to the Emilia (MR/S001255/1) and Indigo Partnership (MR/R023697/1) awards. CL is supported by the NIHR ASSET Global Health Unit award. NV is supported by the UK Medical Research Council (UKRI) in relation to the Emilia project (MR/S001255/1). PCG is supported by the UK Medical Research Council (UKRI) in relation the Indigo Partnership (MR/R023697/1) award. DG is supported by the U.S. National Institutes of Health (R01MH120649). MS is supported by the Global Health Research Unit for Neglected Tropical Diseases at the Brighton & Sussex Medical School, which is funded by the National Institute for Health and Care Research (NIHR) (NIHR131996). KW is supported U.S. National Institutes of Health (K01DA045738).
Publisher Copyright:
© 2024
PY - 2024/4/26
Y1 - 2024/4/26
N2 - Background: Stigma exacerbates power imbalances and societal disparities, significantly impacting diverse identities and health conditions, particularly for low and middle-income countries (LMICs). Though crucial for dismantling harmful stereotypes, and enhancing healthcare utilisation, existing research on anti-stigma interventions is limited with its condition-focused approach. We aimed to thoroughly evaluate peer-reviewed and non-peer-reviewed literature for a comprehensive review of anti-stigma interventions for diverse identities and all health conditions in LMICs. Methods: This review systematically explored peer-reviewed and non-peer-reviewed literature, in ten electronic databases up to January 30, 2024, covering all anti-stigma interventions across various stigmatised identities and health conditions in LMICs. Quality assessment for this systematic review was conducted as per Cochrane Collaboration's suggested inclusions. The review was registered with PROSPERO (Registration: 2017 CRD42017064283). Findings: Systematic synthesis of the 192 included studies highlights regional imbalances, while providing valuable insights on robustness and reliability of anti-stigma research. Most studies used quasi-experimental design, and most centred on HIV/AIDS or mental health related stigma, with very little work on other issues. Certain high-population LMICs had no/little representation. Interpretation: The interventions targeted diverse segments of populations and consequently yielded a multitude of stigma-related outcomes. However, despite the heterogeneity of studies, most reported positive outcomes underscoring the effectiveness of existing interventions to reduce stigma. Funding: This study is supported by the UK Medical Research Council Indigo Partnership (MR/R023697/1) award.
AB - Background: Stigma exacerbates power imbalances and societal disparities, significantly impacting diverse identities and health conditions, particularly for low and middle-income countries (LMICs). Though crucial for dismantling harmful stereotypes, and enhancing healthcare utilisation, existing research on anti-stigma interventions is limited with its condition-focused approach. We aimed to thoroughly evaluate peer-reviewed and non-peer-reviewed literature for a comprehensive review of anti-stigma interventions for diverse identities and all health conditions in LMICs. Methods: This review systematically explored peer-reviewed and non-peer-reviewed literature, in ten electronic databases up to January 30, 2024, covering all anti-stigma interventions across various stigmatised identities and health conditions in LMICs. Quality assessment for this systematic review was conducted as per Cochrane Collaboration's suggested inclusions. The review was registered with PROSPERO (Registration: 2017 CRD42017064283). Findings: Systematic synthesis of the 192 included studies highlights regional imbalances, while providing valuable insights on robustness and reliability of anti-stigma research. Most studies used quasi-experimental design, and most centred on HIV/AIDS or mental health related stigma, with very little work on other issues. Certain high-population LMICs had no/little representation. Interpretation: The interventions targeted diverse segments of populations and consequently yielded a multitude of stigma-related outcomes. However, despite the heterogeneity of studies, most reported positive outcomes underscoring the effectiveness of existing interventions to reduce stigma. Funding: This study is supported by the UK Medical Research Council Indigo Partnership (MR/R023697/1) award.
UR - http://www.scopus.com/inward/record.url?scp=85191302443&partnerID=8YFLogxK
U2 - 10.1016/j.eclinm.2024.102612
DO - 10.1016/j.eclinm.2024.102612
M3 - Article
VL - 72
JO - EClinicalMedicine
JF - EClinicalMedicine
IS - 102612
M1 - 102612
ER -
